LWW lands The Cancer Journal

Share this article:
Wolters Kluwer Health has picked up The Cancer Journal from Jones & Bartlett.

The journal will be published by Lippincott Williams & Wilkins under the new name The Cancer Journal: The Journal of Principles and Practices of Oncology.

Jeff McCaulley, president and CEO of Wolters Kluwer Health, said: “The acquisition of The Cancer Journal is congruent with our strategy to grow our leading positions by extending our proprietary content in the healthcare industry, especially in leading disease states and therapeutic areas.”

LWW also publishes The Journal of Clinical Oncology, Annals of Oncology and Cancer Nursing.

Share this article:
close

Next Article in News

Email Newsletters

More in News

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Fabry disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.

Five things for pharma marketers to know: Wednesday, August 20

Five things for pharma marketers to know: Wednesday, ...

Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma ...